PFE
Pfizer Inc.NYSEHealthcare$28.33-0.77%OpenMarket Cap: $161.09B
As of 2026-04-06
Valuation
P/E (TTM)
20.73
PEG
—
P/B
1.86
P/S
2.57
EV/EBITDA
13.55
DCF Value
$37.59
FCF Yield
5.6%
Div Yield
6.1%
Margins & Returns
Gross Margin
70.3%
Operating Margin
24.7%
Net Margin
12.4%
ROE
8.7%
ROA
9.3%
ROIC
8.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $17.56B | 70.0% | $3.69B | $-1.65B | $-0.29 | $0.43 |
| FY 2025 | $62.58B | 70.3% | $15.44B | $7.77B | $1.36 | $1.72 |
| Q3 2025 | $16.65B | 74.9% | $3.55B | $3.54B | $0.62 | $0.43 |
| Q2 2025 | $14.65B | 64.3% | $3.58B | $2.91B | $0.51 | $0.43 |
| Q1 2025 | $13.71B | 71.7% | $4.62B | $2.97B | $0.52 | $0.43 |
| Q4 2024 | $17.76B | 73.0% | $5.72B | $403.0M | $0.07 | $0.42 |
| FY 2024 | $63.63B | 65.8% | $16.48B | $8.02B | $1.41 | $1.68 |
| Q3 2024 | $17.70B | 60.8% | $4.97B | $4.47B | $0.78 | $0.42 |
| Q2 2024 | $13.28B | 62.1% | $1.88B | $24.0M | $0.00 | $0.42 |
| Q1 2024 | $14.88B | 70.6% | $4.56B | $3.12B | $0.55 | $0.42 |
| Q4 2023 | $14.57B | 41.0% | $-1.26B | $-3.34B | $-0.60 | $0.41 |
| FY 2023 | $59.55B | 50.9% | $5.29B | $2.13B | $0.37 | $1.64 |